Temporary Duty-Free Treatment for FDA-Authorized Parties of Infant Formula Base Powder
Updated: Nov 9, 2022
U.S. Customs and Border Protection (CBP) will provide duty-free treatment of the eligible infant formula base powder entered or withdrawn from warehouse for consumption on or after 12:01 AM Eastern daylight time on October 13, 2022, through 11:59 PM Eastern Standard time on December 31, 2022.
Duty-free treatment will only be provided to importers of base powder to be manufactured into infant formula authorized to be marketed in the United States or subject to an enforcement discretion letter from the Food and Drug Administration (FDA).
For qualified shipments from the FDA-authorized parties, duty-free treatment is limited to certain infant formula base powder classifiable under HTS subheading 1901.90.62 and must be exported to the United States on or before November 14, 2022.
CSMS #53599807 can be found here: CSMS # 53599807 - Temporary Duty-Free Treatment for FDA-Authorized Parties of Infant Formula Base Powder